Reata Pharmaceuticals Inc

Ensign Peak Advisors, Inc

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

126,625

Value ($000)

12,911

Weight

0.0%

2019 Q4 - 2023 Q2 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	12,911	0.0%	126,625	6/30/2023
2023 Q1	5/15/2023	10,763	0.0%	118,375	3/31/2023
2022 Q4	2/13/2023	2,694	0.0%	70,915	12/31/2022
2022 Q3	11/14/2022	1,963	0.0%	78,115	9/30/2022
2022 Q2	8/12/2022	1,907	0.0%	62,736	6/30/2022
2022 Q1	5/16/2022	702	0.0%	21,427	3/31/2022
2021 Q4	2/11/2022	174	0.0%	6,580	12/31/2021
2021 Q2	8/13/2021	1,587	0.0%	11,218	6/30/2021
2021 Q1	5/12/2021	226	0.0%	2,271	3/31/2021
2020 Q4	2/12/2021	281	0.0%	2,271	12/31/2020
2020 Q3	11/12/2020	939	0.0%	9,643	9/30/2020
2020 Q2	8/12/2020	450	0.0%	2,884	6/30/2020
2020 Q1	5/11/2020	335	0.0%	2,324	3/31/2020
2019 Q4	2/14/2020	617	0.0%	3,014	12/31/2019